Please provide your email address to receive an email when new articles are posted on . PrEP adherence and engagement continues to be an issue for young men who have sex with men. PrEP use among this ...

The U.S. Food and Drug Administration approved a generic version of Truvada, the only drug approved so far to use as pre-exposure prophylaxis, a prevention method known as PrEP, which when taken daily ...

The U.S. Food and Drug Administration has approved the first generic version of Truvada, a combination pill used for both HIV treatment and prevention, but it will not soon hit pharmacy shelves, ...

Anne Neilan, MD, a physician-scientist in the division of Infectious Diseases at Massachusetts General Hospital is the senior author of a recently published paper in Clinical Infectious Diseases, ...

The US Food and Drug Administration (FDA) has approved a generic form of the drug Truvada, an antiretroviral and pre-exposure prophylaxis (PrEP) from Gilead Sciences. The approval notice was posted on ...

Gilead Sciences, makers of HIV prevention drug Truvada, have announced that a generic version will be available as early as September 2020. Truvada, also called PrEP, is a daily pill that prevents ...

HHS has announced that Gilead will donate its pre-exposure prophylaxis (PrEP) pill Truvada for up to 200,000 people in a multiyear agreement, just a day after the pharma giant announced that a generic ...

Gilead Sciences announced Wednesday that a generic version of Truvada will be available in September 2020, one year earlier than expected. Truvada is the pill used for HIV pre-exposure prophylaxis, or ...

Gilead Sciences is relaxing its patent on Truvada, the brand name for their pre-exposure prophylaxis (PrEP) medication, allowing Teva Pharmaceuticals to release a generic version in 2020. The news ...

Gilead Sciences, makers of HIV prevention drug Truvada, have announced that a generic version will be available as early as September 2020. Truvada, also called PrEP, is a daily pill that prevents ...